Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma

Journal of Glaucoma

Volumn 17, Issue 4, 2008, Pages 303-307

  Sheha, Hosam ^a,b,c   Kheirkhah, Ahmad ^b   Taha, Hamid ^a  

^a Saudi German Hospitals Group   (Saudi Arabia)

^b OCULAR SURFACE CENTER   (United States)

^c RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

Amniotic membrane; Mitomycin C; Refractory glaucoma; Trabeculectomy

Indexed keywords

ANTIGLAUCOMA AGENT; DEXAMETHASONE PLUS TOBRAMYCIN; MITOMYCIN C; ALKYLATING AGENT; ANTIHYPERTENSIVE AGENT; MITOMYCIN;

ADULT; AMNIOTIC MEMBRANE TRANSPLANTATION; ARTICLE; CHOROIDAL EFFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLAUCOMA; HIGH RISK PATIENT; HUMAN; HYPHEMA; INCAPSULATED BLEB; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCLERA; TISSUE TRANSPLANTATION; TRABECULECTOMY; TREATMENT OUTCOME; AMNION; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOVASCULAR GLAUCOMA; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PLASTIC SURGERY; TRANSPLANTATION;

ALKYLATING AGENTS; AMNION; ANTIHYPERTENSIVE AGENTS; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA, NEOVASCULAR; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SCLERA; SURGICAL FLAPS; TONOMETRY, OCULAR; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 47749121433     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31815c3a47     Document Type: Article

References (28)

1. Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149-170.
2. Chen C. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pac Acad Ophthalmol. 1983;9:172-177.
3. Heuer DK, Parrish RK, Gressel MG, et al. 5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology. 1984; 91:384-394.
4. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314-346.
5. Yoon PS, Singh K. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol. 2004;15:141-146.
6. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmology. 1993;100:928-939.
7. Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001; 10:237-249.
8. Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51-77.
9. Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocular Surface. 2004;2:201-211.
10. Tseng SCG, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocular Surface J. 2004;2:177-187.
11. Fujishima H, Shimazaki J, Shinozaki N, et al. Trabeculectomy with the use of amniotic membrane for uncontrolled glaucoma. Ophthalmic Surg Lasers. 1998;29:428-431.
12. Zhong Y, Zhou Y, Wang K. Effect of amniotic membrane on filtering bleb after trabeculectomy in rabbit eyes. Yan Ke Xue Bao. 2000;16:73-76; 83.
13. Demir T, Turgut B, Akyol N, et al. Effects of amniotic membrane transplantation and mitomycin C on wound healing in experimental glaucoma surgery. Ophthalmologica. 2002;216:438-442.
14. Demir T, Turgut B, Celiker U, et al. Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery. Doc Ophthalmol. 2003;107:87-92.
15. Lu H, Mai D. Trabeculectomy combined amniotic membrane transplantation for refractory glaucoma. Yan Ke Xue Bao. 2003;19: 89-91.
16. Yue J, Hu CQ, Lei XM, et al. Trabeculectomy with amniotic membrane transplantation and combining suture lysis of scleral flap in complicated glaucoma. Zhonghua Yan Ke Za Zhi. 2003;39:476-480.
17. Wang L, Liu X, Zhang P, et al. An experimental trial of glaucoma filtering surgery with amniotic membrane. Yan Ke Xue Bao. 2005;21: 126-131.
18. Zheng K, Huang Z, Zou H, et al. The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C. Yan Ke Xue Bao. 2005;21:84-87; 91.
19. Drolsum L, Willoch C, Nicolaissen B. Use of amniotic membrane as an adjuvant in refractory glaucoma. Acta Ophthalmol Scand. 2006;84:786-789.
20. Bruno CA, Eisengart JA, Radenbaugh PA, et al. Subconjunctival placement of human amniotic membrane during high risk glaucoma filtration surgery. Ophthalmic Surg Lasers Imaging. 2006;37: 190-197.
21. Eliezer RN, Kasahara N, Caixeta-Umbelino C, et al. Use of amniotic membrane in trabeculectomy for the treatment of glaucoma: a pilot study. Arq Bras Oftalmol. 2006;69:309-312.
22. Lee S-H, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
23. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology. 1992;99:1471-1476.
24. Tseng SCG, Li D-Q, Ma X. Suppression of transforming growth factor isoforms, TGF-β receptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325-335.
25. Lee S-B, Li D-Q, Tan DTH, et al. Suppression of TGF-β signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. 2000;20: 325-334.
26. Li W, He H, Kawakita T, et al. Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro. Exp Eye Res. 2006;82:282-292.
27. Barton K, Budenz D, Khaw PT, et al. Glaucoma filtration surgery using amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42:1762-1768.
28. Ophir A. Encapsulated filtering bleb. A selective review - new deductions. Eye. 1992;6(Pt 4):348-352.